Source:http://linkedlifedata.com/resource/pubmed/id/19034002
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2008-11-26
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1534-6080
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
27
|
pubmed:volume |
86
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1351
|
pubmed:meshHeading | |
pubmed:year |
2008
|
pubmed:articleTitle |
Targeting of the fifth complement (C5) component to fight graft impairment after ischemia-reperfusion injury.
|
pubmed:affiliation |
Department of Medical Microbiology and Immunology, University of Toledo Medical College, Toledo, OH 43614, USA. stanislaw.stepkowski@uth.tmc.edu
|
pubmed:publicationType |
Journal Article,
Comment
|